GNRH1 and coronary artery disorder: Another study comparing GnRH agonists and antagonists in men with prior CVD found a decrease in risk of heart failure (HR, 0.46; 95% CI, 0.26–0.79) and ischemic heart disease (HR, 0.26; 95% CI, 0.11–0.65) [30].